A career development award from the AACR enabled Eddy Yang, MD, PhD, to investigate combinations of targeted treatments in triple negative breast cancer. Now the chair of radiation medicine at the University of Kentucky College of Medicine, Dr. Yang shares how the grant came at a pivotal time in his career.
Research Funding Impact
Since 1993, the AACR has awarded more than $540 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.
AACR grant recipient June M. Chan, ScD, has studied how diet and exercise, among other factors, contribute to progression in prostate cancer.
AACR-Novocure grantee investigates the impact of novel TTFields therapy on residual glioblastoma disease
Sara G.M. Piccirillo, PhD, was inspired to study glioblastoma whilst an undergraduate student at the National Carlo Besta Neurological Institute in her hometown of Milan, Italy. Now an assistant professor at the University of New Mexico Health Sciences Center, Dr. Piccirillo, was awarded the AACR-Novocure Tumor Treating Fields (TTFields) Research Grant in 2021 to investigate the impact of TTFields on residual glioblastoma disease.
A fellowship from the AACR enabled Jeffrey Engelman, MD, PhD, to stay in the lab and make the discoveries that launched a successful career that has spanned academic medicine, a pharmaceutical company, and a biotech startup.
AACR-Bayer Innovation and Discovery Grantee identifies expression signatures associated with immune checkpoint inhibitor resistance in bladder cancer
More than 80,000 people are diagnosed in the US with bladder cancer each year. 2019 AACR Grant Recipient Joshua Meeks, MD, PhD, sought to define immune checkpoint inhibitor resistance mechanisms in bladder cancer.
As we continue our celebration of 30 years of impact of the AACR Research Grants Program, we feature the first recipient of an AACR Clinical and Translational Cancer Research Fellowship (supported by Amgen) -- 1993 AACR Research Fellow Michael Jensen, MD.
AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Help Fund the Unconventional
Born through an innovative partnership between the AACR and the UBS Oncology Impact Fund (OIF) managed by MPM Capital, the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants program aims to promote and support creative, paradigm-shifting cancer research which might not be funded through conventional channels.
Dr. Chloe Steen Shares How the AACR-AstraZeneca Lymphoma Research Fellowship Allowed Her to Explore the Microenvironment of Lymphoma
Led by a fascination with Lymphoma, Chloe Steen, PhD, has dedicated her research and career to developing and employing computational methods for dissecting the tumor microenvironment of lymphoma, and other types of cancer. Here, she shares how receiving 2019 AACR-AstraZeneca Lymphoma Research Fellowship represented a key stepping stone in her career.
Impacting community through community: AACR-Genentech Cancer Disparities Fellow provides a window into Latino smokers’ perceptions on physical activity and the importance of community engagement
A growing share of US adult smokers – Hispanic/Latino adults – have been found to be less likely to receive advice to quit and use proven cessation treatments than non-Hispanic white adults. 2021 AACR-Genentech Cancer Disparities Fellow Francisco Cartujano, MD, seeks to address tobacco-related disparities in Latinos by promoting smoking cessation and physical activity using a mobile intervention.